Seth Rodgers is an entrepreneurial CEO and CTO with extensive senior leadership experience in start-up companies. He has worked closely with senior management and board members to raise more than $30 million in angel and venture capital. With expertise in company and capital formation, product development, market analysis, strategy, and technical sales, Seth has guided NeuroSave through patent protection, engineering, fund-raising and both successful animal and human trials. He holds a PhD in chemical engineering from the Massachusetts Institute of Technology and has broad technical expertise across medical devices, life sciences, reactor design and automation.